Melinda Thach

We are saddened by the passing of Rachna T. Shroff, MD, MS, a renowned physician-scientist who treated people with pancreatic cancer and advanced treatment options for patients facing pancreatic and hepatobiliary cancers. Dr. Shroff passed away following a battle with an aggressive cancer. She was 47. Through her groundbreaking research and leadership in clinical trials, Dr. Shroff helped move the field forward and expand possibilities for patients. She also collaborated with PanCAN on research related to our Know Your Tumor® precision medicine service, contributing to a deeper understanding of pancreatic cancer. We extend our heartfelt condolences to her loved ones, colleagues and the many patients whose lives she touched. 💜 Read more from the @UAZMedTucson at 🔗 bit.ly/4jprjTS.

When we come together as a community, we change the story for patients and families. Join us on Saturday, April 24, 2027, at an event near you for #PanCANPurpleStride, the ultimate walk to end pancreatic cancer. 💜 Visit 🔗 pcan.at/PurpleStride2027 to learn more.

Join us for our second Right Track Live event, hosted by PanCAN Chief Scientific & Medical Officer Anna Berkenblit, MD, MMSc. We will bring together leading pancreatic neuroendocrine tumor (PNET) experts to share the latest information, answer common questions and provide practical insights into diagnosis, treatment and ongoing research. ⏺️ Save your seat at 🔗 pcan.at/RightTrackLive.

From meal planning and recipe ideas to facts about enzymes and tips from dietitians, PanCAN has you covered when it comes to information on nutrition. It's a subject as varied as the people facing pancreatic cancer, and we want to encourage you to eat foods that keep you strong, connected and full of joy. 💜 Visit 🔗 pancan.org/diet-and-nutritio… to learn more about how PanCAN can help.

One of the most common conditions associated with pancreatic cancer may also be one of the least understood: Cancer cachexia. Sometimes known as wasting syndrome, cancer cachexia is the loss of 5% or more of body weight in six months. It is caused by many different factors that scientists are still trying to understand. It differs from weight loss because it is unintentional and happens even if the patient is still eating enough food to maintain their weight. Cancer cachexia is also different from weight loss because it affects muscles too. Instead of just losing weight from excess fat, cancer cachexia can cause significant muscle-wasting that can make patients feel weak and unable to withstand often intense cancer treatments. This muscle wasting can also include weakening of muscles of the heart and lungs, which makes early intervention important. This Cancer Cachexia Awareness Day, visit 🔗 pcan.at/po6j38 to learn more about this condition that affects more than 90% of people living with pancreatic cancer.

On this episode of PancChat, host @AlisynCamerota is joined by Dr. Eileen O’Reilly of @MSKCancerCenter to discuss what the recent approval of RASONQUE™ (daraxonrasib) means for people with pancreatic cancer. 💊 Dr. O’Reilly breaks down RAS signaling, common RAS mutations including G12D, G12V and G12R, how RAS-targeting drugs work, what RAS mutation testing involves and what “RAS wild type” means. Visit 🔗 pcan.at/PancChat to listen. The PancChat podcast is a collaboration between @LetsWinPC and PanCAN, and this episode is sponsored by @RevMedicines.